HER2-negative metastatic BC: First-line nivolumab, bevacizumab, paclitaxel shows promise in phase 2July 27, 2022Breast Cancer
Concurrent use of DOAC and tamoxifen does not increase hemorrhage risk in BCJuly 27, 2022Breast Cancer
DBT lowers risk for advanced BC diagnosis in women with dense breasts and at high riskJuly 27, 2022Breast Cancer
HER2-low metastatic BC: Phase 3 establishes trastuzumab deruxtecan as a new standard-of-care July 27, 2022Breast Cancer
Oncology PracticeHormone therapy didn’t increase recurrence or mortality in women treated for breast cancerJuly 21, 2022Breast Cancer
Oncology PracticeAmazon involved with new cancer vaccine clinical trialJuly 15, 2022Breast CancerPreventive CareMelanoma
Oncology PracticeSelect patients with breast cancer may skip RT after lumpectomyJuly 12, 2022Breast CancerASCO Breast Cancer
Oncology PracticeStudy confirms BRCA1 and BRCA2 linked to seven cancersJuly 8, 2022Gynecologic CancerBreast CancerMetastatic Breast CancerGastrointestinal CancerGenitourinary Cancer
Oncology PracticeSociogenomics may explain race disparities in breast cancer mortalityJuly 8, 2022Breast CancerMetastatic Breast Cancer
Oncology PracticeQuality of life benefit exaggerated in some cancer studiesJuly 7, 2022Gastrointestinal CancerBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
Oncology PracticeCancer may increase risk of type 2 diabetesJuly 1, 2022Lung CancerGastrointestinal CancerBreast CancerNeuro-oncologyGenitourinary Cancer
Highlights in Early Breast Cancer From the 2022 American Society of Clinical Oncology Annual Meeting June 29, 2022Breast Cancer
Key Abstracts in Metastatic Breast Cancer From the 2022 American Society of Clinical Oncology Annual Meeting June 29, 2022Breast Cancer
Oncology Practice‘Unexpected’: Breast cancer spreads most during sleepJune 28, 2022Metastatic Breast CancerBreast Cancer
